Triple-negative breast cancer (TNBC) is a distinct subtype of breast cancer characterized by the absence of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expression in immunohistochemistry (1). Here, ESR1 is linked to triple-negative breast carcinoma.